Corporate GovernanceJul 14, 2026, 05:06 PM
SBC Medical Group Non-Compliant with Nasdaq Independence Rules
AI Summary
SBC Medical Group Holdings Inc. notified Nasdaq of non-compliance with independent director and audit committee requirements following a director's departure. Nasdaq has provided a cure period until July 9, 2027, or earlier, for the company to regain compliance by appointing a new independent director. Additionally, stockholders approved amendments to the company's certificate of incorporation, and the Board adopted amended bylaws, primarily to update corporate governance provisions related to director elections, removal, and other technical changes.
Key Highlights
- SBC Medical Group notified Nasdaq of non-compliance with independent director and audit committee rules.
- Non-compliance resulted from director Mike Sayama's decision not to seek re-election.
- Nasdaq granted a cure period until July 9, 2027, or the next annual shareholders' meeting.
- The current Board has 4 members, with only 2 independent directors, short of the majority requirement.
- The Audit Committee has 2 independent directors, falling short of the 3-member requirement.
- The Company plans to appoint a fifth independent director to regain compliance.
- Stockholders approved amendments to the Company's Restated Charter, including changes to director election and removal.
- The Board approved Amended and Restated Bylaws to reflect Delaware law and federal securities laws.
Price Impact
More from SBC